Clinical implications of the molecular subtypes of diffuse large B-cell lymphoma.
about
CD99 expression and newly diagnosed diffuse large B-cell lymphoma treated with rituximab-CHOP immunochemotherapy.Prognostic and Clinicopathological Value of Survivin in Diffuse Large B-cell Lymphoma: A Meta-AnalysisHow many diseases are colorectal cancer?Moving forward in HIV-associated cancer.Predicting early post-chemotherapy adverse events in patients with hematological malignancies: a retrospective study.
P2860
Clinical implications of the molecular subtypes of diffuse large B-cell lymphoma.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Clinical implications of the molecular subtypes of diffuse large B-cell lymphoma.
@en
Clinical implications of the molecular subtypes of diffuse large B-cell lymphoma.
@nl
type
label
Clinical implications of the molecular subtypes of diffuse large B-cell lymphoma.
@en
Clinical implications of the molecular subtypes of diffuse large B-cell lymphoma.
@nl
prefLabel
Clinical implications of the molecular subtypes of diffuse large B-cell lymphoma.
@en
Clinical implications of the molecular subtypes of diffuse large B-cell lymphoma.
@nl
P2860
P1433
P1476
Clinical implications of the molecular subtypes of diffuse large B-cell lymphoma.
@en
P2093
Brian T Hill
John Sweetenham
P2860
P304
P356
10.3109/10428194.2011.626882
P577
2012-01-05T00:00:00Z